![The Sanofi iBGStar blood glucose monitor (BGM), which connects directly into the Apple iPhone and iPod touch, allows people with insulin-dependent diabetes to manage the blood glucose levels Stock Photo - Alamy The Sanofi iBGStar blood glucose monitor (BGM), which connects directly into the Apple iPhone and iPod touch, allows people with insulin-dependent diabetes to manage the blood glucose levels Stock Photo - Alamy](https://c8.alamy.com/comp/G51FR0/the-sanofi-ibgstar-blood-glucose-monitor-bgm-which-connects-directly-G51FR0.jpg)
The Sanofi iBGStar blood glucose monitor (BGM), which connects directly into the Apple iPhone and iPod touch, allows people with insulin-dependent diabetes to manage the blood glucose levels Stock Photo - Alamy
![Sanofi India on X: "What's the difference between the results from your glucometer test and an HbA1c test? Regular blood sugar monitoring is a must for good diabetes management. #100InsulinStories #100YearsofInsulin https://t.co/9tqwFKlABv" / Sanofi India on X: "What's the difference between the results from your glucometer test and an HbA1c test? Regular blood sugar monitoring is a must for good diabetes management. #100InsulinStories #100YearsofInsulin https://t.co/9tqwFKlABv" /](https://pbs.twimg.com/ext_tw_video_thumb/1440897299647909890/pu/img/ZbaojE8P7POINv3m.jpg)
Sanofi India on X: "What's the difference between the results from your glucometer test and an HbA1c test? Regular blood sugar monitoring is a must for good diabetes management. #100InsulinStories #100YearsofInsulin https://t.co/9tqwFKlABv" /
![ADA 2021: Hanmi's GLP-1 drug, returned by Sanofi, curbs cardiovascular, kidney issues while tackling Type 2 diabetes | Fierce Biotech ADA 2021: Hanmi's GLP-1 drug, returned by Sanofi, curbs cardiovascular, kidney issues while tackling Type 2 diabetes | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1624915296/GettyImages-1147159749_edited.jpeg/GettyImages-1147159749_edited.jpeg?VersionId=xFNze_XP2iaWdIPrSC7bivT7ac5Naq_c)
ADA 2021: Hanmi's GLP-1 drug, returned by Sanofi, curbs cardiovascular, kidney issues while tackling Type 2 diabetes | Fierce Biotech
![FDA approves first Glucose Monitoring System without fingersticks by Abbott Laboratories; Sanofi and Innovation Health announce a digital therapeutics pilot program for Type 2 diabetics | by The Health Prospect Global | Medium FDA approves first Glucose Monitoring System without fingersticks by Abbott Laboratories; Sanofi and Innovation Health announce a digital therapeutics pilot program for Type 2 diabetics | by The Health Prospect Global | Medium](https://miro.medium.com/v2/resize:fit:1000/1*wVs311xTZSGM2cOOt7u3kQ.jpeg)